US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Clinical Trial Market Research Reports & Industry Analysis

RSS Feeds

Clinical Trial Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Dopaminergic system Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Dopaminergic system Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
DP1 Receptor (Prostaglandin D2 receptor) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... receptor) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The DP1 Receptor (Prostaglandin D2 receptor) Antagonists Report helps to identify emerging players ...  |  read more...
USD 1,250
DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonists. The main objective of this report ...  |  read more...
USD 1,250
Elastase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Elastase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Elastase Inhibitors- ...  |  read more...
USD 1,250
Endothelin Receptor (ET) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Endothelin Receptor (ET) Antagonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Entry Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Entry Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Entry Inhibitors- ...  |  read more...
USD 1,250
Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 (EGFL7) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 (EGFL7) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 ...  |  read more...
USD 1,250
Factor IX -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Factor IX Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Factor IX- ...  |  read more...
USD 1,250
Factor IX A Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Factor IX A Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Factor VIIa Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Factor VIIa Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Factor VIII Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Factor VIII Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Farnesoid X Receptor (FXR) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Farnesoid X Receptor (FXR) Agonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Farnesyl Diphosphate Synthase (FPPS) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Farnesyl Diphosphate Synthase (FPPS) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Farnesyl Protein Transferase (FPTase) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Farnesyl Protein Transferase (FPTase) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Fatty Acid Amide Hydrolase (FAAH) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FAAH) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fatty Acid Amide Hydrolase (FAAH) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Fc-Gamma Receptor Antagonist -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fc-Gamma Receptor Antagonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Protein (FAP or Seprase) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Activation Protein (FAP or Seprase) Inhibitors Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FGF-1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor 1 (FGF-1) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 2 (FGFR2) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 3 (FGFR3) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors Report helps ...  |  read more...
USD 1,250
FK506 Binding Protein (FKBP) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The FK506 Binding Protein (FKBP) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
FK506 Binding Protein 12 (FKBP12) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FKBP12) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The FK506 Binding Protein 12 (FKBP12) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Follicle-Stimulating Hormone Receptor (FSH Receptor or FSHR) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Follicle-Stimulating Hormone Receptor (FSH Receptor or FSHR) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Follicle-Stimulating Hormone Receptor (FSH Receptor or ...  |  read more...
USD 1,250
G Protein-Coupled Receptor 119 (GPR119) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (GPR119) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The G Protein-Coupled Receptor 119 (GPR119) Agonists Report helps to identify emerging players ...  |  read more...
USD 1,250
G2 Checkpoint Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The G2 Checkpoint Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15